High-Throughput Screening Market Trends

  • Report ID: 3521
  • Published Date: Sep 09, 2025
  • Report Format: PDF, PPT

High-Throughput Screening Market Growth Drivers and Challenges:

Growth Drivers

  • Growing Demand for Drugs– On account of the increasing prevalence of chronic disorders across the globe has increased the demand for medicines for treatment. Further, the growing use of HTS for the drug development process is estimated to drive market growth. The number of drug users worldwide is expected to increase by over 10% by 2030.

  • Rising Geriatric Population – Owing to a weak immune system elderly population is more prone to various diseases such as dementia, high blood pressure, and diabetes, which is estimated to drive market growth. As of 2021, the elderly population in India is predicted to increase by over 9%.

  • Increasing Health Spending – Increased government programs and investments in medication research, are anticipated to drive the market growth According to the most recent expenditure data, in 2020, health spending in the US rose by over 9%.

  • Growing Pharmaceutical and Biotechnology Sectors – It is expected that the growing launch of new and advanced drugs, and strong investment in the biotech and pharmaceutical industries, are anticipated to drive market growth. According to estimates, the biotechnology sector in India has grown to a value of over USD 80 billion in 2022.

Challenges

  • Difficulties in Assay Development – To create secondary assays, HTS goes through several difficult stages. It is more costly since the complexity of the assay affects both the time and cost, as a result, it is less adopted by some academic research laboratories.
  • Exorbitant Cost of HTS Instruments– High maintenance costs, and other indirect expenses, increase the total cost of HTS instruments, which is one of the major factors predicted to slow down the market growth.
  • Need for a Large Capital Investment
  • Lack of Skilled Professionals

Base Year

2025

Forecast Period

2026-2035

CAGR

10.7%

Base Year Market Size (2025)

USD 27.14 billion

Forecast Year Market Size (2035)

USD 75 billion

Regional Scope

  • North America (U.S. and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, Malaysia, Australia, South Korea, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC, North Africa, South Africa, Rest of the Middle East and Africa)

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of high-throughput screening is evaluated at USD 29.75 billion.

The global high-throughput screening market size was worth over USD 27.14 billion in 2025 and is poised to grow at a CAGR of around 10.7%, reaching USD 75 billion revenue by 2035.

North America high-throughput screening market will hold around 40.6% share by 2035, driven by growing pharmaceutical R&D and chronic disease burden.

Key players in the market include Carna Biosciences, Inc., Agilent Technologies, Inc., Thermo Fisher Scientific, Tecan Trading AG, Promega Corporation, Hamilton Company, BPS Bioscience, Inc., PerkinElmer Inc., Merck KGaA.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos